Detection of Point Mutations of Bcl10 Gene in Hepatocellular Carcinoma Tissues: Report of 46 Cases

Cheng Jihua,Leng Xisheng,Cai Shengli,Cao Zongxian,Cao Guang,Du Ruyu

DOI: https://doi.org/10.1002/(sici)1098-1004(200005)15:5<482::aid-humu17>3.0.co;2-z

2000-01-01

Human Mutation

Abstract:BCL10 was found to have truncated mutations at a high frequency in MALT (mucosa‐associated lymphoid tissue) B cell lymphomas. We examined the mutations of BCL10 gene in human primary liver cancer using non‐isotopic PCR‐SSCP. Three exons were examined in both cancer and non‐HCC adjacent liver tissues. For each exon, six PCR products with abnormal bands were sequenced to verify those mutations. 56.5% samples were revealed a C to G mutation at position 5744 (g5744C>G) of the first exon of BCL10 gene; 54.3% samples were revealed a T deletion mutation at position 11311 (g11311delT) of the second exon of BCL10 gene; 45.7% samples were revealed a C to T mutation at position 14116 (g14116C>T) of the third exon of BCL10 gene. Similar mutation types were found in tumor‐adjacent tissues at a lower frequency. The single base changes result in a truncated BCL10 protein expression. Serum alpha‐fetoprotein (AFP) level, the tumor size had no significant relationship with BCL10 mutation. Hum Mutat 15:482–483, 2000. © 2000 Wiley‐Liss, Inc.